Accordingly, cholinesterases are the main targets in neurodegenerative disorders or diseases such as Alzheimer’s, Parkinson’s, myasthenia gravis, etc. Therefore, many different compounds are being investigated as cholinesterase inhibitors and potential neurotherapeutics, including oximes [4,5,6]. The gene discussed is BCHE; the disease is myasthenia gravis.